Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma

William G. Herrington, Denis C. Talbot, Michael M. Lahn, John T. Brandt, Sophie Callies, Ray Nagle, Christopher G. Winearls, Ian S.D. Roberts

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences